Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$753M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$717M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$653M |
| 5 |
Microsoft
MSFT
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TotalEnergies
TTE
|
+$427M |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$380M |
| 3 |
STJ
St Jude Medical
STJ
|
+$235M |
| 4 |
JPMorgan Chase
JPM
|
+$211M |
| 5 |
LLTC
Linear Technology Corp
LLTC
|
+$175M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.74% |
| 2 | Healthcare | 5.25% |
| 3 | Financials | 4.26% |
| 4 | Communication Services | 3.9% |
| 5 | Consumer Discretionary | 3.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3651
CALL
iShares Russell 2000 Value ETF
IWN
$14.5B
| $366K | ﹤0.01% |
3,100
+3,000
| +3,000% | +$356K |
|
3652
CALL
PTC Therapeutics
PTCT
$5.87B
| $366K | ﹤0.01% |
+37,200
| New | +$450K |
|
3653
Amkor Technology
AMKR
$13.5B
| $365K | ﹤0.01% |
31,582
-45,214
| -59% | -$466K |
|
3654
Mercury Systems
MRCY
$6.64B
| $365K | ﹤0.01% |
9,331
+1,649
| +21% | +$58.6K |
|
3655
Nelnet
NNI
$4.85B
| $365K | ﹤0.01% |
8,328
+7,622
| +1,080% | +$364K |
|
|
NXTM
3656
DELISTED
NxStage Medical Inc.
NXTM
| $365K | ﹤0.01% |
13,616
+7,927
| +139% | +$219K |
|
|
ELME
3657
Elme Communities
ELME
$146M
| $364K | ﹤0.01% |
11,619
+1,415
| +14% | +$45.1K |
|
3658
CALL
Oshkosh
OSK
$9.45B
| $364K | ﹤0.01% |
5,300
-1,300
| -20% | -$89.3K |
|
3659
CALL
Piper Sandler
PIPR
$5.09B
| $364K | ﹤0.01% |
+22,800
| New | +$404K |
|
3660
CALL
Magna International
MGA
$18.3B
| $363K | ﹤0.01% |
8,400
+2,700
| +47% | +$118K |
|
|
FFNW
3661
DELISTED
First Financial Northwest, Inc
FFNW
| $363K | ﹤0.01% |
20,532
+20,416
| +17,600% | +$401K |
|
3662
PUT
ProShares UltraShort QQQ
QID
$253M
| $362K | ﹤0.01% |
238
-120
| -34% | -$198K |
|
3663
CALL
KLA
KLAC
$255B
| $361K | ﹤0.01% |
38,000
-87,000
| -70% | -$766K |
|
|
3664
PUT
KLA
KLAC
$255B
| $361K | ﹤0.01% |
38,000
-14,000
| -27% | -$123K |
|
|
ENDP
3665
PUT
DELISTED
Endo International plc
ENDP
| $360K | ﹤0.01% |
32,300
-18,764
| -37% | -$233K |
|
3666
Interparfums
IPAR
$3.93B
| $359K | ﹤0.01% |
9,826
+6,777
| +222% | +$235K |
|
3667
UMB Financial
UMBF
$11B
| $359K | ﹤0.01% |
4,758
+1,472
| +45% | +$113K |
|
|
GCI
3668
DELISTED
Gannett Co., Inc
GCI
| $359K | ﹤0.01% |
42,725
-8,698
| -17% | -$77.7K |
|
3669
The Ensign Group
ENSG
$10.5B
| $358K | ﹤0.01% |
20,318
+16,489
| +431% | +$298K |
|
3670
Kulicke & Soffa
KLIC
$4.71B
| $358K | ﹤0.01% |
17,660
-96,061
| -84% | -$1.85M |
|
3671
Sanmina
SANM
$11B
| $358K | ﹤0.01% |
8,819
-121,284
| -93% | -$4.69M |
|
|
MTOR
3672
CALL
DELISTED
MERITOR, Inc.
MTOR
| $358K | ﹤0.01% |
20,900
| – | – |
|
3673
CALL
Box
BOX
$4.37B
| $357K | ﹤0.01% |
21,900
+1,200
| +6% | +$20.3K |
|
|
ZNGA
3674
PUT
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $357K | ﹤0.01% |
125,300
+54,200
| +76% | +$146K |
|
3675
CALL
Calix
CALX
$2.38B
| $355K | ﹤0.01% |
+49,000
| New | +$347K |
|
Similar funds
Barclays's Q1 2017 Portfolio in Review
As of Q1 2017, Barclays held 7,315 positions worth $91.9B, down 0.67% from $92.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $6.86B in Q1 2017, closing 393 positions and reducing 3,105 holdings. Its most notable exit was St Jude Medical, an estimated $235M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.7% of assets, up from 4.7% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in iPath S&P VEQTOR ETN worth $95.8M.
- Barclays's largest Q1 2017 buy was iPath S&P VEQTOR ETN: 670,000 shares worth $95.8M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q1 2017, an estimated $1.04B increase.
- Barclays's biggest Q1 2017 reduction was TotalEnergies, cutting an estimated $427M.
- Barclays fully exited St Jude Medical in Q1 2017, selling an estimated $235M.
- Barclays's ten largest holdings make up 34% of its $91.9B portfolio in Q1 2017.
- Barclays opened 572 new positions and closed 393 in Q1 2017.
- Barclays's portfolio value fell 0.67% quarter-over-quarter to $91.9B.
Based on Barclays's 13F filing for Q1 2017, filed 15 May 2017.